pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4640 |
Genomic Coordinates | chr6: 30890883 - 30890972 |
Description | Homo sapiens miR-4640 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4640-5p | ||||||||||||||||||||||||
Sequence | 9| UGGGCCAGGGAGCAGCUGGUGGG |31 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CDC5L | ||||||||||||||||||||
Synonyms | CDC5, CDC5-LIKE, CEF1, PCDC5RP, dJ319D22.1 | ||||||||||||||||||||
Description | cell division cycle 5 like | ||||||||||||||||||||
Transcript | NM_001253 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CDC5L | |||||||||||||||||||||
3'UTR of CDC5L (miRNA target sites are highlighted) |
>CDC5L|NM_001253|3'UTR 1 AGTACAGTTTATATTCTGTCACAGGATTAATTAATTGCCGGTTTTCATACTCTAGAAGGCTGAAACTGATGTTTATCTTC 81 ATTGACAAATTTACCCACCATCTGTGGTTTTTCAGTTGTTTATTTTAAATGATATCGATCTTACACATTCTGTGTATAAA 161 GACCTTAACTCCACAGGACGGACATTTTAGAGTTTAAATTATTAAGGCTATCATTCTTTTAGTAATGTCATATTTGCAAA 241 CTTTTTTAGTTTTGGCCTTTAATTTAAAAAGCCTAATTTTAAAGTGCTGCCTGTGAGTAACTCTTGAATAAAAACAAAAT 321 ATAAAAAATTGAGAATGTAGCCTTTTGTTTGAAGTAATTAGATACTTAAGAGTGCCTGCAAACCAGCAGCTATGTACTCT 401 GTGTCATATTTAATGAGTAACTCTTGGGTAATCAAAATGGTGATGCAGTATCTTAAACACTTAAGAGGCAGTTCTTTGTG 481 GCTTTGTTAGTTTCAGCAAAGAGTGGTCATTTCTGTATACACTGACAAGTTAGATTAACTTTTTAGTACCTCAAATTTTT 561 TTTTTGTTAATATCACTTTAAAGAAGGTCTCTTGTCTGCCAGCTACTTAAATAATTTATGGGTCAGGGCTTAAAAGATTT 641 AACTTCCTTGCCCCATTATTTTCTTATAAGTATTTTTTGACAAAGGCATTTTAAAAGTTAATTTCAAGAAGGCCATCAAA 721 CTTAAAGCTCTATGTTTAGCCTAAGAAGTCAGTTACATCAGTGTAGAATTTGGGGAATGGATAGAGGTGGAGATATTTAA 801 TTTTATATAATTCATATAAATTGATTTAGTTACAGTATCAGTTGGCTACAAGCTCATTATAGACTAGCAATGTTTTGACA 881 TCACCAAAAACGTTTGCCCAGTCTTAGAATACTAGGGACTATAGGAAGGGAAGGGATTCATTCATTCATTCGATATTGAA 961 TGTATACCCTGTGCCAGAGTCTTAGAGAGAGAACAACAAACAAAATAGGCCTAGTTCTTGTTTAGTAGAGCTTATAGTCT 1041 TTTGAGAATGACAGACAATTAAAATCCAAATGTTTATTTGGTGATTCTTATGTGTCAGACACTTAAGTGTTGGGAGATAA 1121 GCAGTTATTAAGACAGAGTTCTTGCTCTCATGGAGGTGACATTAGTGGGGAGGAGATACTAAGTATGTCCAGGGAAAGTA 1201 TCAGACCATGAGTTTTAGATTCTGTGGAGGAAATTAAAGTAGGGTGATTATGAGATAGTGAATGAGTGGCTATTTTAGAC 1281 TGGACGATCAAAGAGACCTCTTGGAAGGCAGCTATGCTCACCACTATACCACTGCACTGTGCCGCACCGTACCACTATAA 1361 GCTGCACGGCCAAAGAGACCTCTTAAAGAAGTAACATTTAAGATAACATGTGATTGACATTTTAGAATGGGCTATCCTTG 1441 TGAGATTCAAGGAAAGAACATCCTAGGTGGAGTGAATAGCAAACATAAAGCCTCTTTTGTATGTTTGAGGAACAAAAAGG 1521 ACAATGCAGCTAGAGTGTCAAGAATGGCATTTCTGTATATAAGACCTCGTTGTATAGAGCCACATAAATAAGGCTATAAT 1601 AAGGAATTTGGATCTTACTTTAAATATGATAAGAATCGATGAGAAGATCTAAGCAAAGGAATGACATGATCAGATTTGGT 1681 TTTAGAAACATCACTATCTCCTTAGTGTGTAAAATCTCACCAGGCTGGAGATAGGGAAGCCAGTCCAATTAGGAGCCTGA 1761 TGCAGTGATCCAGACAAAAAAATAATAGTGATTCTAACTAGAGTCCAGGTAATAGTAGTGGAGATATGTGGAGAGACATG 1841 ATAGGTATATACTTAATAGTCTTATCAGACGATAAATTGATATTTTCCTGGTGTGTAGTCACTTAATTCAAATACTTTTT 1921 TCAGTAAGTTCTGGGTTTTCTAGGAAAAACTTCAGTATCATCAGTGAATAATGATAGTGTTTCTTCTGATAGTTTTATTT 2001 CACTTTTATTGCATGTTTTGTTATCTGAAATGTTTAGGACAATGTTAACAATAATGATGTTAGACATTTTTTTTTCTTAT 2081 TTTAATGGGAATGTCCATAGTTTTAAGTTTGCTGTTGGGAGTTAGATAGTCTTTATCTGAAAGACAGTGTCTCTCTTTTA 2161 GTTTTTAAAGAGTTTGAATTAGAAATGGCTCTGGAACTTTAAACAGTATACCATTTGGGCATCTATTAAAGCATTCATAT 2241 AATTGTTCTCATTTGATGTTTTGATGAGGTATATTAATAGATTTTCCCACATTAAATCATCTTTGCACTCCTGGAATCAG 2321 GTAGATTAATTTTTAAAAGAAATTTTAAAGGATTTATAGTTTATTTGCACTTTTTGTAGACTTGAATTATATGGATTTAA 2401 AAGTTGATCTAATATTAATAAAGGCTCACTTTGTTTTCAAAATTTGAAGTAATTCACATACTTATAGCCTAAAAAAATCG 2481 GCAGGAATTACAAAATTTCAAAACTGGCACATTGTAAACTGCATATGCATTTGCCAGGTAGTGGTGCCACTTGAAATGGT 2561 GAACAGACACACTGTTATCCTTTGTCAGTATCCTGTAAAGCCCAGGATTCTTTACCAGCACCATACAGCGATTTTGGTGA 2641 CTATTTTAACATTCACACTGAGGCCAGGGGTGGTGAGTCATGCCTGTAATCCTAGCACTTTGGGAGGCCAAGGTGGGAGG 2721 ATCATTTGAGCTCAGGAGTTCAAGATTAGCCTGGGTAACATAGTGAGACCCTGTCTCTATTAAAAAATAATAATAAAAAT 2801 AACATTCACATTGGTATTGTTCACTAAGGTATTGGTTGTTAAGGCATTCATTAAGGTATTGTTAAAACTTGTGTTAAGCA 2881 TGTTAAAGTCTCAGTAACTTTGGGATAGAAATAAAATGTGATAAAAAGCTGAAAGAAACCACCACAAGGGAGAGTCCTTT 2961 TTGAAATATTAGAGACATAATGCTGTCTAATAAAAAACGACATCAAAGAAAAACTACACTACAGTGACTGCAGACTTAAT 3041 GTTGGCCAACCATGCATCCTCCCTAGAAATGCATTTGAATTTGATTTACTAATCTTTTATTTAGGAAATTTACATTTTTA 3121 CATTAGTGAGATTGGTCTTTTGGGCTATTGTACTTTTTTTTTTTTTTTTTTGAGATGGAGTCTTGCTCTCTCACCCAGGC 3201 TGGAGTGCAGTAGTGCAATCTTGGCCCACTGCAACCTCTGCCTCCTGGGCTCGAGTGATTCTCTGCCTCAGCCTTCCAAG 3281 TAGCTGGGACTACAGGCATGTGCCACCGCACCTGGCTAATTTTTGTGTTTTTAGTAGAGATGGGGTTTTGCTATGTTGGC 3361 CAGGCTGGTCTTGAATTCCTGACCTCAGGTGATCCACCTACCTCGGCCTCCCAAAGTGCTAGAATTACAGGTGTGAGCCA 3441 CCATGCCCAGCCTGGTTATTGTATTTTGATATTGGGATTTTGCTAGCTCTCTAAAGTAAATAGGATAACTGTATATCTTT 3521 TTCTGTGCATTAAGCAGTTATAACATGGGAATGATTTGTTCATGAAAGGTTGAAAGTCTGTACTTACAGAACTTTTGAGT 3601 TCACAGTGCTTTCTGGAAATAATTTCTTTATAACTGTCAGTTTCTTTTGTGACTATTATGTTACCTATTTTTAAATTTAA 3681 GCAACTTTAAATTAAAAAAATTGTTTTTAAAAT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293/HeLa | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1067870. RNA binding protein: AGO2. Condition:Ago2 IP-seq (mitotic cells)
... - Kishore S; Gruber AR; Jedlinski DJ; Syed et al., 2013, Genome biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Gruber AR; Jedlinski DJ; Syed et al. - Genome biology, 2013
BACKGROUND: In recent years, a variety of small RNAs derived from other RNAs with well-known functions such as tRNAs and snoRNAs, have been identified. The functional relevance of these RNAs is largely unknown. To gain insight into the complexity of snoRNA processing and the functional relevance of snoRNA-derived small RNAs, we sequence long and short RNAs, small RNAs that co-precipitate with the Argonaute 2 protein and RNA fragments obtained in photoreactive nucleotide-enhanced crosslinking and immunoprecipitation (PAR-CLIP) of core snoRNA-associated proteins. RESULTS: Analysis of these data sets reveals that many loci in the human genome reproducibly give rise to C/D box-like snoRNAs, whose expression and evolutionary conservation are typically less pronounced relative to the snoRNAs that are currently cataloged. We further find that virtually all C/D box snoRNAs are specifically processed inside the regions of terminal complementarity, retaining in the mature form only 4-5 nucleotides upstream of the C box and 2-5 nucleotides downstream of the D box. Sequencing of the total and Argonaute 2-associated populations of small RNAs reveals that despite their cellular abundance, C/D box-derived small RNAs are not efficiently incorporated into the Ago2 protein. CONCLUSIONS: We conclude that the human genome encodes a large number of snoRNAs that are processed along the canonical pathway and expressed at relatively low levels. Generation of snoRNA-derived processing products with alternative, particularly miRNA-like, functions appears to be uncommon.
LinkOut: [PMID: 23706177]
|
CLIP-seq Support 1 for dataset GSM1067870 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293/HeLa / Ago2 IP-seq (mitotic cells) |
Location of target site | ENST00000371477.3 | 3UTR | GGCCCACUGCAACCUCUGCCUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23706177 / GSE43666 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000371477.3 | 3UTR | CAAUCUUGGCCCACUGCAACCUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
87 hsa-miR-4640-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT100106 | ABT1 | activator of basal transcription 1 | 2 | 8 | ||||||||
MIRT248144 | LMBR1L | limb development membrane protein 1 like | 2 | 2 | ||||||||
MIRT327062 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT347231 | GATAD2A | GATA zinc finger domain containing 2A | 2 | 2 | ||||||||
MIRT450221 | CENPN | centromere protein N | 2 | 2 | ||||||||
MIRT451264 | NDUFA11 | NADH:ubiquinone oxidoreductase subunit A11 | 2 | 2 | ||||||||
MIRT452701 | C1orf226 | chromosome 1 open reading frame 226 | 2 | 2 | ||||||||
MIRT453212 | CERS1 | ceramide synthase 1 | 2 | 2 | ||||||||
MIRT454822 | POLR2J3 | RNA polymerase II subunit J3 | 2 | 2 | ||||||||
MIRT454883 | RAD50 | RAD50 double strand break repair protein | 2 | 2 | ||||||||
MIRT455783 | TAF8 | TATA-box binding protein associated factor 8 | 2 | 2 | ||||||||
MIRT455858 | TMEM254 | transmembrane protein 254 | 2 | 2 | ||||||||
MIRT457615 | UPK3BL | uroplakin 3B like 1 | 2 | 2 | ||||||||
MIRT457822 | ITPRIP | inositol 1,4,5-trisphosphate receptor interacting protein | 2 | 4 | ||||||||
MIRT458344 | NOC2L | NOC2 like nucleolar associated transcriptional repressor | 2 | 2 | ||||||||
MIRT458376 | ITM2C | integral membrane protein 2C | 2 | 2 | ||||||||
MIRT458928 | SAMD4B | sterile alpha motif domain containing 4B | 2 | 2 | ||||||||
MIRT459066 | WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 2 | 2 | ||||||||
MIRT460138 | ASB16 | ankyrin repeat and SOCS box containing 16 | 2 | 2 | ||||||||
MIRT460818 | FSTL4 | follistatin like 4 | 2 | 2 | ||||||||
MIRT461285 | COX10 | COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor | 2 | 2 | ||||||||
MIRT462738 | EFNB1 | ephrin B1 | 2 | 2 | ||||||||
MIRT464556 | UBTF | upstream binding transcription factor, RNA polymerase I | 2 | 2 | ||||||||
MIRT477910 | DUSP2 | dual specificity phosphatase 2 | 2 | 2 | ||||||||
MIRT479073 | CNNM4 | cyclin and CBS domain divalent metal cation transport mediator 4 | 2 | 4 | ||||||||
MIRT479534 | CDC5L | cell division cycle 5 like | 2 | 4 | ||||||||
MIRT485628 | EEPD1 | endonuclease/exonuclease/phosphatase family domain containing 1 | 2 | 2 | ||||||||
MIRT489896 | PPIC | peptidylprolyl isomerase C | 2 | 4 | ||||||||
MIRT490737 | SRCIN1 | SRC kinase signaling inhibitor 1 | 2 | 2 | ||||||||
MIRT491201 | MLLT1 | MLLT1, super elongation complex subunit | 2 | 4 | ||||||||
MIRT492681 | PHYHIP | phytanoyl-CoA 2-hydroxylase interacting protein | 2 | 2 | ||||||||
MIRT494593 | ATG7 | autophagy related 7 | 2 | 2 | ||||||||
MIRT495061 | PADI3 | peptidyl arginine deiminase 3 | 2 | 4 | ||||||||
MIRT496623 | TMEM67 | transmembrane protein 67 | 2 | 2 | ||||||||
MIRT497177 | ZBTB40 | zinc finger and BTB domain containing 40 | 2 | 2 | ||||||||
MIRT498217 | TLN2 | talin 2 | 2 | 2 | ||||||||
MIRT498306 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT499668 | NPHP3 | nephrocystin 3 | 2 | 2 | ||||||||
MIRT508080 | ANKRD52 | ankyrin repeat domain 52 | 2 | 2 | ||||||||
MIRT509707 | ANKRD23 | ankyrin repeat domain 23 | 2 | 2 | ||||||||
MIRT509841 | FOS | Fos proto-oncogene, AP-1 transcription factor subunit | 2 | 2 | ||||||||
MIRT512814 | ARRDC2 | arrestin domain containing 2 | 2 | 2 | ||||||||
MIRT513353 | SLIT1 | slit guidance ligand 1 | 2 | 2 | ||||||||
MIRT514293 | FXYD5 | FXYD domain containing ion transport regulator 5 | 2 | 2 | ||||||||
MIRT516598 | FAM89A | family with sequence similarity 89 member A | 2 | 4 | ||||||||
MIRT516616 | DARS2 | aspartyl-tRNA synthetase 2, mitochondrial | 2 | 2 | ||||||||
MIRT518348 | CCL5 | C-C motif chemokine ligand 5 | 2 | 2 | ||||||||
MIRT520130 | WSB1 | WD repeat and SOCS box containing 1 | 2 | 2 | ||||||||
MIRT522072 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 2 | 2 | ||||||||
MIRT526461 | OSBPL5 | oxysterol binding protein like 5 | 2 | 2 | ||||||||
MIRT528278 | MBL2 | mannose binding lectin 2 | 2 | 2 | ||||||||
MIRT534844 | RAB15 | RAB15, member RAS oncogene family | 2 | 4 | ||||||||
MIRT542245 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | 2 | 2 | ||||||||
MIRT543299 | ZNF585B | zinc finger protein 585B | 2 | 2 | ||||||||
MIRT552456 | ZNF410 | zinc finger protein 410 | 2 | 2 | ||||||||
MIRT553641 | TJAP1 | tight junction associated protein 1 | 2 | 2 | ||||||||
MIRT557103 | HOXA3 | homeobox A3 | 2 | 2 | ||||||||
MIRT570782 | FANCA | Fanconi anemia complementation group A | 2 | 2 | ||||||||
MIRT630912 | ZMAT2 | zinc finger matrin-type 2 | 2 | 2 | ||||||||
MIRT631034 | ZNF878 | zinc finger protein 878 | 2 | 2 | ||||||||
MIRT639017 | AAK1 | AP2 associated kinase 1 | 2 | 2 | ||||||||
MIRT648596 | ZYG11B | zyg-11 family member B, cell cycle regulator | 2 | 2 | ||||||||
MIRT648939 | ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | 2 | 2 | ||||||||
MIRT652834 | TACO1 | translational activator of cytochrome c oxidase I | 2 | 2 | ||||||||
MIRT659347 | CSRP1 | cysteine and glycine rich protein 1 | 2 | 2 | ||||||||
MIRT664163 | APOBEC3F | apolipoprotein B mRNA editing enzyme catalytic subunit 3F | 2 | 2 | ||||||||
MIRT670511 | ZSCAN22 | zinc finger and SCAN domain containing 22 | 2 | 2 | ||||||||
MIRT671246 | TMEM41B | transmembrane protein 41B | 2 | 2 | ||||||||
MIRT672120 | ATP6V0A2 | ATPase H+ transporting V0 subunit a2 | 2 | 2 | ||||||||
MIRT672313 | CD3D | CD3d molecule | 2 | 2 | ||||||||
MIRT672543 | BRMS1L | breast cancer metastasis-suppressor 1 like | 2 | 2 | ||||||||
MIRT673036 | SGPL1 | sphingosine-1-phosphate lyase 1 | 2 | 2 | ||||||||
MIRT673814 | DARS | aspartyl-tRNA synthetase | 2 | 2 | ||||||||
MIRT674858 | GINM1 | glycoprotein integral membrane 1 | 2 | 2 | ||||||||
MIRT674970 | SH3BP2 | SH3 domain binding protein 2 | 2 | 2 | ||||||||
MIRT675185 | KIF1C | kinesin family member 1C | 2 | 2 | ||||||||
MIRT675219 | UGDH | UDP-glucose 6-dehydrogenase | 2 | 2 | ||||||||
MIRT675558 | MED16 | mediator complex subunit 16 | 2 | 2 | ||||||||
MIRT682566 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | 2 | 2 | ||||||||
MIRT684640 | PDE4C | phosphodiesterase 4C | 2 | 2 | ||||||||
MIRT689722 | ATXN2 | ataxin 2 | 2 | 2 | ||||||||
MIRT693594 | SLC39A1 | solute carrier family 39 member 1 | 2 | 2 | ||||||||
MIRT704745 | CDKN2B | cyclin dependent kinase inhibitor 2B | 2 | 2 | ||||||||
MIRT712779 | ZNF154 | zinc finger protein 154 | 2 | 2 | ||||||||
MIRT718118 | OTOF | otoferlin | 2 | 2 | ||||||||
MIRT720115 | SAMD4A | sterile alpha motif domain containing 4A | 2 | 2 | ||||||||
MIRT720275 | EIF1AD | eukaryotic translation initiation factor 1A domain containing | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|